BioHealth Innovation

What BioHealth Innovation does

BioHealth Innovation, Inc. (BHI) is a public-private nonprofit innovation intermediary founded in 2011 and headquartered at 1 Church Street, Suite 801 in Rockville, Maryland. The organization operates exclusively in the BioHealth Capital Region spanning Maryland, Virginia, and Washington D.C., and its stated purpose is to translate market-relevant research into commercial success by connecting management, funding, and markets with biohealth innovators. BHI draws on a deep bench of 60+ Entrepreneurs-in-Residence, an advisory board drawn from major life sciences companies (Johnson & Johnson/JLABS, AstraZeneca, GSK, Amgen, Emergent BioSolutions), real estate and capital partners (Alexandria Real Estate Equities, M&T Bank), and academic institutions (Johns Hopkins, George Mason University, Virginia Tech/Fralin Biomedical Research Institute, University System of Maryland).

BHI's service portfolio comprises four core programs (Entrepreneur-in-Residence, Non-Dilutive Funding Assistance, International Soft Landing Assistance, and Business Resources) plus a content and events layer anchored by the BioTalk podcast, a weekly newsletter with 710+ editions, and the annual BioHealth Capital Region Week now in its 12th year. The BHCR Week umbrella includes the BioHealth Capital Region Forum, the Crab Trap Competition, and the BioHealth Capital Region Investment Conference. BHI also co-participates in regional showcases such as the Maryland Stem Cell Research Fund Tech Showcase and BioHorizons at the Johns Hopkins Applied Physics Laboratory. The organization's technology surface is minimal: it operates a content website, a podcast distribution channel, an email newsletter, an active LinkedIn presence, and event-management tooling rather than a proprietary software platform.

As a nonprofit, BHI is funded through government grants, program fees, event registration and sponsorship revenue, and membership or partnership contributions from regional stakeholders. Its pricing is not publicly disclosed and it does not sell a commercial product. Revenue depends materially on sustained public-private support and on the annual cycle of BHCR Week and adjacent programming. Customer-facing engagement is delivered through direct advisory work by EIRs, university and institution partnerships, and event-driven interactions with early-stage biohealth companies, academic researchers, experienced life sciences professionals, and government and economic development organizations across the BioHealth Capital Region.

Name

BioHealth Innovation

Legal name

BioHealth Innovation, Inc.

Website

https://biohealthinnovation.org

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

BioHealth Innovation is a Rockville, Maryland-based nonprofit innovation intermediary that connects biohealth startups, researchers, and entrepreneurs in the BioHealth Capital Region with management expertise, funding sources, and markets through EIR advisory programs, the BioTalk podcast, and the annual BioHealth Capital Region Week.

Ownership category

akta.pro rank

Product category

Life Sciences Innovation Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Health Access & Social Care Innovations (Community Health, Telehealth for Underserved) (BPAGALAG)

Keywords

• Innovation intermediary services
• Biohealth commercialization
• Entrepreneur in residence
• Non-dilutive funding assistance
• Technology transfer services

Headquarters

HQ city

Rockville

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Program Services and Grants: BHI operates as a public-private nonprofit that generates revenue through government grants, program fees, and potentially membership or sponsorship arrangements with regional partners. The organization connects biohealth innovators with funding sources including non-dilutive funding assistance programs.
2. Event Revenue: The organization hosts signature events including the annual BioHealth Capital Region Week, Crab Trap Competition, and regional events like BioHorizons, which generate revenue through registration fees and sponsorships.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

BioHealth Innovation (BHI) is a public-private nonprofit innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets with biohealth innovators. The organization operates programs including Entrepreneur-in-Residence (EIR), Non-Dilutive Funding Assistance, International Soft Landing Assistance, and Business Resources, and hosts the annual BioHealth Capital Region Week alongside the BioTalk podcast and weekly newsletter.

Product overview

BioHealth Innovation (BHI) is a single, unified innovation intermediary service rather than a platform-plus-modules architecture. BHI connects management, funding, and markets with BioHealth Innovators through a coordinated set of programs and services, including the Entrepreneur-in-Residence Program, Non-Dilutive Funding Assistance, International Soft Landing Assistance, and BioHealth Innovation Business Resources. The organization also hosts the BioTalk Podcast and organizes the annual BioHealth Capital Region Week, which encompasses the BioHealth Capital Region Forum, Crab Trap Competition, and Investment Conference. The BHI Newsletter provides regular weekly updates to the regional ecosystem.

Differentiator

Problem solved

Functional benefit

Products and services

• Entrepreneur-in-Residence (EIR) Program

Quantifiable outcome

• BioHealth Capital Region named Top 3 U.S. biopharma cluster for fourth consecutive year by GEN
• +1 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core.

• Montgomery County Economic Development Corporation (MCEDC)coreStrategic or Co-development Partner · 13 May 2026BHI collaborates with MCEDC on regional economic development, talent initiatives, and biohealth ecosystem growth. MCEDC's Jared Smith appeared on BioTalk discussing building Montgomery County's innovation ecosystem.
• Maryland Stem Cell Research Fund (MSCRF)coreStrategic or Co-development Partner · 12 May 2026MSCRF hosted its 3rd Annual Stem Cell and Regenerative Medicine Tech Showcase in Baltimore. BHI supports and participates in MSCRF programming to advance stem cell research commercialization in Maryland.
• Alexandria Real Estate EquitiescoreStrategic or Co-development PartnerJoel Marcus, Executive Chairman & Founder of Alexandria Real Estate Equities (NYSE:ARE), serves on BHI's Board. Alexandria is a leading life science real estate REIT and key ecosystem partner.
• JLABS @ Washington DCcoreStrategic or Co-development PartnerRachel Rath, Head of JLABS @ Washington DC, serves on BHI Board. JLABS is Johnson & Johnson's innovation arm providing lab space and mentorship to startups.
• US PharmacopeiacoreStrategic or Co-development PartnerAnthony Lakavage, SVP Global External Affairs at USP, serves on BHI Board. USP hosts the annual BioHealth Capital Region Week at its Rockville facility.
• George Mason UniversitycoreStrategic or Co-development PartnerAmy Adams, Executive Director of the Institute for BioHealth Innovation at George Mason University, serves on BHI Board. GMU is a key academic partner in the ecosystem.
• University System of MarylandcoreStrategic or Co-development PartnerDr. Jay Perman, Chancellor of University System of Maryland, serves on BHI Board. USM includes UMB and other institutions key to the biohealth ecosystem.
• Virginia Tech / Fralin Biomedical Research InstitutecoreStrategic or Co-development PartnerDr. Michael Friedlander, VP for Health Sciences and Technology at Virginia Tech, serves on BHI Board. The Fralin Biomedical Research Institute hosts ecosystem events.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• MassBio: Massachusetts-based industry association serving the life sciences cluster with programming, policy advocacy, and ecosystem services — a directly analogous regional industry intermediary to BHI's role in the BioHealth Capital Region.
• Cleveland Clinic Innovations: Cleveland Clinic's commercialization arm that translates clinical and research IP into startups and licenses — a comparable academic-to-commercial intermediation function in another regional cluster.
• NCBiotech (North Carolina Biotechnology Center): State-funded nonprofit that drives life sciences industry growth in North Carolina through funding, programming, and cluster development — structurally similar to BHI's public-private nonprofit model serving a competing regional cluster.
• Biocom: California life sciences association operating the San Diego and broader California cluster with advocacy, capital access programming, and member services — a regional peer competing for biopharma cluster leadership.
• MBC BioLabs: San Francisco / San Diego biotech co-working and accelerator providing lab space and programming to early-stage life sciences startups — a comparable intermediation model with physical infrastructure.
• BioGenerator: St. Louis-based nonprofit that creates and funds biohealth startups from academic IP, runs an EIR-style support model, and provides lab space and grant assistance — highly comparable to BHI's EIR and Non-Dilutive Funding Assistance programs.
• California Life Sciences (CLSA): Trade association representing the California life sciences industry, providing networking, capital formation, and policy advocacy services analogous to BHI's regional convening role.

Emerging players

• IndieBio (SOSV): Venture-backed biotech accelerator providing capital, lab space, and mentorship to early-stage biology startups — a comparable but for-profit, venture-funded intermediation model.

Broad incumbents

• JLABS (Johnson & Johnson Innovation): J&J's no-strings-attached incubator network providing lab space, mentorship, and capital connections to biotech startups; JLABS @ Washington DC sits on BHI's board, and JLABS is a comparable (but better-capitalized) innovation intermediary.
• BIO (Biotechnology Innovation Organization): The largest global biotech trade association hosting BIO International Convention (where BHI's CEO represents the BHCR region); a broader incumbent whose convening platform overlaps with BHI's BHCR Week.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/biohealth-innovation-inc-
• Xx.com/biohealthinnov
• Facebookfacebook.com/biohealthinnovation

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioHealth Innovation